Articles On Avita Medical (ASX:AVH)

Shares in regenerative medicine company AVITA Medical Inc (ASX: AVH) closed 19 per cent lower today after the company revised down its full-year revenue guidance due to a slowdown in sales during December. The Perth-founded AVITA, which pr...

Highlights Cooling inflation boosts market confidence amid potential rate cuts. Financial heavyweights CBA and NAB rise over 2%, driving the ASX upward. Miners recover as key stocks like BHP and RIO rebound from recent losses. The...

Wound care company Avita Medical slumps ~19% on downgrade of its earnings guidance Infection-control medtech Next Science hit with legal action by a former employee Biotech Orthocell achieves third consecutive quarter of record revenue  ...

Highlights  Core inflation drops, leading to a recovery in the ASX.  Miners show strong performance, while uranium stocks take a hit.  Avita Medical (AVH) downgraded revenue outlook, causing a sharp dip.  The Australian sharemarke...

The S&P/ASX 200 Index (ASX: XJO) has rebounded from a poor start and pushing higher on Wednesday. In afternoon trade, the benchmark index is up 0.4% to 8,317.1 points. Four ASX shares that have failed to rise with the market today are...

Highlights  Australian share market opens lower amid inflation concerns.  Avita Medical's guidance downgrade drives a sharp decline.  Mixed performance seen across key sectors and major companies.  The Australian share market expe...

AVITA Medical Inc (ASX: AVH) shares are having a tough time on Wednesday. In morning trade, the ASX All Ords stock is down 17% to $3.62. Why is this ASX All Ords stock down 17%? This commercial-stage regenerative medicine company's shares a...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the year with another decline. At the time of writing, the benchmark index is down 0.7% to 8,174.7 points. Four ASX shares that are not letting that hol...

The S&P/ASX 200 Index (ASX: XJO) is having a disappointing finish to the year. At the time of writing, the benchmark index is down 0.7% to 8,174.7 points. Four ASX shares that are falling more than most today are listed below. Here's...

The S&P/ASX 200 Index (ASX: XJO) is on form again after returning from the Christmas break. At the time of writing, the benchmark index is up 0.4% to 8,255.7 points. Four ASX shares that are rising more than most today are listed below...

The ASX 200 ended on a positive closing note before Santa’s arrival (a fair bit) later this evening with a 0.29% gain, adding a short 24 points to 8,217. Real Estate was today’s top sector leader, ending the day up 0.82%, followed by Hea...

The S&P/ASX 200 Index (ASX: XJO) is having a volatile session but is currently on course to record a small gain. In early afternoon trade, the benchmark index is up slightly to 8,208.5 points. Four ASX shares that are rising more than m...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

AVITA Medical Inc (ASX: AVH) shares are having a strong start to the day. In morning trade, the ASX healthcare stock is up over 7% to $4.10. Why is this ASX healthcare stock jumping? Investors have been buying the regenerative medicine comp...

The ASX 200 is expected to stay ever so slightly in the green at open on Christmas Eve after the Wall Street Santa rush (mostly) ploughed on through weaker-than-expected U.S. consumer confidence reported on Monday. The Magnificent Seven...

Morgans sees opportunities among several ASX healthcare stocks in 2025 Broker looking at stocks with near-term catalysts or sold down with good entry opportunities Morgans’ Christmas stocking has mix of up-and-comers alongside mature names...

Syntara aims for FDA ‘breakthrough’ therapy status for its myelofibrosis drug candidate FAK! More promising results from Amplia’s pancreatic cancer trial Oh, you shouldn’t have! Broker Morgans’ Christmas biotech hamper   Armed with encour...

When it comes to medical devices, improving the lives of clinicians is just as important as improving the lives of patients. If both these aims can be achieved, that’s the sweet spot. In the case of Avita Medical (ASX:AVH), the company’s ap...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX health stocks fall 1.3% in past five days, while broader market is marginally up 0.7%  Neuren soars on sale of priority review voucher and $50 million share buyback Neurizon releases positive preclinical results on lead drug candidate...

Emyria says the Trump administration’s expected liberalisation of psychedelic therapies was the likely reason for yesterday’s 42% share spurt  Avita Medical brings it home with an Aussie distribution deal  EBR System expects US approval fo...

If you are a fan of small cap ASX shares, then you will be pleased to know that analysts have recently named a number as buys. Here's what you need to know about these shares from the small side of the market: AVITA Medical Inc (ASX: AVH)...

Several ASX healthcare companies have upcoming catalysts, which can be a focal point for healthcare investors Dimerix forecasts the second interim analysis of its ACTION 3 global phase III trial of DMX-200 to treat FSGS in around mid-CY25...

The ASX200 closed 0.84% at 8,295 points. The market remains buoyant in the wake of Trump’s election in the United States, and the expectation China will ramp up stimulus measures. IT finished the session the best performing sector, up...

AVITA Medical (Nasdaq: RCEL, ASX: AVH), a leader in regenerative medicine with its proprietary RECELL technology, reported a substantial increase in revenue for the third quarter ended 30 September 2024. The company recorded commercial reve...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

ASX health stocks fall 2.15% in past five days, while broader market down 1.42%  MedAdvisor drops 30% on latest quarterly result as MicroX and Mach 7 also fall Micro X reports a ‘ho-hum’ results, while AGMs so far remain rather uneventful ...

Investors that are looking for exposure to the small side of the market, might want to check out the small cap ASX shares listed below. That's because they were recently named as buys by brokers and tipped to rise strongly from current leve...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

Many analysts believe that interest rate cuts will put a rocket under small cap ASX shares, which have been underperforming during the rate hike cycle. And while Australian interest rates may not be heading lower until next year, it could p...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

The Dicker Data Ltd (ASX: DDR) share price is having a difficult finish to the week. In morning trade, the wholesale computer hardware and software distributor's shares are down 9.5% to $9.16. Investors have been hitting the sell button in...

ASX health stocks rise 0.8% past five days as broader market lifts 3.7%  Morgans says ProMedicus ‘produced yet another record result’ with net profit of $82.8m in FY24  CSL falls on FY24 results but Morgans still bullish on ASX’s largest h...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7832.00 + 28.00 0.36% S&P ASX 200 7850.70 +...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7829.00 + 59.00 0.76% S&P ASX 200 7826.80 +...

It's been a decent, if unspectacular, day for the S&P/ASX 200 Index (ASX: XJO) so far this Tuesday. At the time of writing, the ASX 200 has gained a tentative 0.18% and is up to just under 7,830 points. But the performance of the JB Hi-...

The CAR Group Limited (ASX: CAR) share price had a strong start to the week on Monday. The ASX 100 share ended the session 4.5% higher at $35.14. Investors were buying the auto listings company's shares following the release of its full y...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7762.00 + 3.00 0.04% S&P ASX 200 7813.70 + 3...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a positive fashion. The benchmark index rose 0.45% to 7,813.7 points. Will the market be able to build on this on Tuesday? Here are five things to watch: ASX 200 expected...

This Monday, the S&P/ASX 200 Index (ASX: XJO) and, by extension, many ASX shares had a stellar start to the trading week. After soaring on Friday, the ASX 200 kept up the momentu...

It's been a great start to the trading week this Monday for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares by extension. At the time of writing, the ASX 200 has added a healthy 0.42%, pulling the index back up over 7,800 points. B...

The S&P/ASX 200 Index (ASX: XJO) is on form again on Monday. At the time of writing, the benchmark index is up 0.5% to 7,818.1 points. Four ASX shares that are rising more than most today are listed below. Here's why they are pushing hi...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AZJ)) - Auriz...

Dicker Data Ltd (ASX: DDR) has kicked off the week with a positive start, announcing an 11 cents per share dividend before the market opened today. The announcement has driven DDR shares up 4% at the time of writing, with the stock now...

The CAR Group Ltd (ASX: CAR) share price is leaping higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) auto listings company closed on Friday trading for $33.64. In morning trade on Monday, shares are changing hands for $34.92...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

The Avita Medical Ltd (ASX: AVH) share price is rallying hard on Friday, up 10% to trade at $14.82 at the time of writing. This follows the release of the company's financial results for the quarter ending 30 June 2024. For context,...

Neuren shows promise in Angelman drug but shares down 7pc Avita aims for profitability by Q3 FY25 IDT lands $2.5-$4m mRNA contract with Sanofi   Neuren’s Angelman drug shows promise Market darling Neuren Pharmaceuticals (ASX:NEU) has just...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Indications are the ASX is poised for a strong session today. World Overnight SP...